V. V. Myllyl�

648 total citations
11 papers, 507 citations indexed

About

V. V. Myllyl� is a scholar working on Psychiatry and Mental health, Neurology and Organic Chemistry. According to data from OpenAlex, V. V. Myllyl� has authored 11 papers receiving a total of 507 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Psychiatry and Mental health, 4 papers in Neurology and 2 papers in Organic Chemistry. Recurrent topics in V. V. Myllyl�'s work include Parkinson's Disease Mechanisms and Treatments (4 papers), Migraine and Headache Studies (2 papers) and EEG and Brain-Computer Interfaces (2 papers). V. V. Myllyl� is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (4 papers), Migraine and Headache Studies (2 papers) and EEG and Brain-Computer Interfaces (2 papers). V. V. Myllyl� collaborates with scholars based in Finland. V. V. Myllyl�'s co-authors include Esa Heinonen, A. Pakarinen, Kalervo Suominen, Tarja Haapaniemi, K. A. Sotaniemi, Ari Illi, Arja Rautio, Olavi Pelkonen, E. Hokkanen and Aydin Tekay and has published in prestigious journals such as Annals of Neurology, Movement Disorders and Journal of Neurology.

In The Last Decade

V. V. Myllyl�

11 papers receiving 475 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
V. V. Myllyl� Finland 9 215 191 170 82 72 11 507
Margherita Estienne Italy 13 202 0.9× 72 0.4× 234 1.4× 120 1.5× 42 0.6× 21 568
Kıvılcım Gücüyener Türkiye 12 114 0.5× 62 0.3× 145 0.9× 71 0.9× 18 0.3× 33 357
Dragoslav Sokić Serbia 14 361 1.7× 186 1.0× 198 1.2× 119 1.5× 12 0.2× 57 688
E Mesdjian France 13 202 0.9× 23 0.1× 260 1.5× 90 1.1× 52 0.7× 35 462
R. Eugene Ramsay United States 11 196 0.9× 59 0.3× 188 1.1× 83 1.0× 8 0.1× 12 371
Sen-yang Lang China 17 228 1.1× 61 0.3× 175 1.0× 119 1.5× 9 0.1× 39 681
John R. Green United States 10 91 0.4× 49 0.3× 73 0.4× 34 0.4× 14 0.2× 18 312
G. J. A. Macphee United Kingdom 12 205 1.0× 347 1.8× 198 1.2× 164 2.0× 5 0.1× 24 746
Herbert R. Henney United States 14 89 0.4× 284 1.5× 69 0.4× 96 1.2× 10 0.1× 30 657
Rossella Manco Italy 11 258 1.2× 13 0.1× 243 1.4× 69 0.8× 59 0.8× 19 485

Countries citing papers authored by V. V. Myllyl�

Since Specialization
Citations

This map shows the geographic impact of V. V. Myllyl�'s research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. V. Myllyl� with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. V. Myllyl� more than expected).

Fields of papers citing papers by V. V. Myllyl�

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. V. Myllyl�. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. V. Myllyl�. The network helps show where V. V. Myllyl� may publish in the future.

Co-authorship network of co-authors of V. V. Myllyl�

This figure shows the co-authorship network connecting the top 25 collaborators of V. V. Myllyl�. A scholar is included among the top collaborators of V. V. Myllyl� based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. V. Myllyl�. V. V. Myllyl� is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Suominen, Kalervo, Tarja Haapaniemi, V. V. Myllyl�, et al.. (2004). Nocturnal cardiac autonomic regulation in Parkinson?s disease. Clinical Autonomic Research. 14(2). 119–124. 16 indexed citations
2.
Haapaniemi, Tarja, et al.. (2001). [123I]?-CIT SPECT demonstrates decreased brain dopamine and serotonin transporter levels in untreated parkinsonian patients. Movement Disorders. 16(1). 124–130. 59 indexed citations
3.
Kallio, Mika, Juha T. Korpelainen, Uolevi Tolonen, et al.. (2000). Levodopa, bromocriptine and selegiline modify cardiovascular responses in Parkinson's disease. Journal of Neurology. 247(11). 868–874. 50 indexed citations
4.
Knip, Mikael, Juha S. Tapanainen, A. Pakarinen, et al.. (1999). Valproate-induced hyperandrogenism during pubertal maturation in girls with epilepsy. Annals of Neurology. 45(4). 444–450. 117 indexed citations
5.
Heinonen, Esa & V. V. Myllyl�. (1998). Safety of Selegiline (Deprenyl) in the Treatment of Parkinson??s Disease. Drug Safety. 19(1). 11–22. 57 indexed citations
6.
Myllyl�, V. V., et al.. (1995). Serum sex hormone levels after replacing carbamazepine with oxcarbazepine. European Journal of Clinical Pharmacology. 47(5). 461–4. 68 indexed citations
7.
Myllyl�, V. V., et al.. (1993). Effect of entacapone, a COMT inhibitor, on the pharmacokinetics of levodopa and on cardiovascular responses in patients with Parkinson's disease. European Journal of Clinical Pharmacology. 45(5). 419–423. 71 indexed citations
8.
Ala‐Hurula, V., et al.. (1979). Systemic availability of ergotamine tartrate after three successive doses and during continuous medication. European Journal of Clinical Pharmacology. 16(5). 355–360. 28 indexed citations
9.
Ala‐Hurula, V., et al.. (1979). Systemic availability of ergotamine tartrate after oral, rectal and intramuscular administration. European Journal of Clinical Pharmacology. 15(1). 51–55. 29 indexed citations
10.
Heikkinen, E.R., et al.. (1975). Cyclic adenosine-3?,5?-monophosphate concentration and enzyme activities of cerebrospinal fluid in meningitis of children. European Journal of Pediatrics. 120(4). 243–250. 8 indexed citations
11.
Myllyl�, V. V., et al.. (1975). Cerebrospinal fluid concentration and urinary excretion of cyclic adenosine-3?, 5?-monophosphate in various diseases of children. European Journal of Pediatrics. 118(4). 259–264. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026